Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly appoints senior VP for corporate affairs and communications

Leigh Ann Pusey joins from the American Insurance Association

Leigh-Ann PuseyEli Lilly has appointed Leigh Ann Pusey as its senior vice president, corporate affairs and communications and will be a member of the firm’s executive committee reporting directly to president and chief executive officer, David Ricks.

Previously serving as president and CEO of trade body the American Insurance Association (AIA), Pusey’s expertise ranges from leadership to policy solutions.

Ricks said: “Leigh Ann brings a wealth of public affairs leadership experience to Lilly and at a particularly important time for our industry.

“Her ability to convene conversations and drive proactive policy solutions will be critical in our efforts to promote and sustain medical innovation so patients and the health care system benefit from a new era of medicine.”

Pusey is recognised as one of the top lobbyists in Washington, DC and in 2012 was named by the National Journal as one of the 25 ‘Most Influential Women in Washington’.

She also serves in various capacities for a number of organisations, including as a member of the US Chamber of Commerce’s Committee of 100 and board member of the Insurance Institute for Highway Safety.

Prior to joining AIA, Pusey had been the deputy assistant to President George Bush for the White House Office of Public Liaison and deputy director of communications for the Republican National Committee.

15th May 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics